dc.contributorFed Univ State Rio de Janeiro UNIRIO
dc.contributorMcGill Univ
dc.contributorUniversidade Federal de São Paulo (UNIFESP)
dc.contributorUniversidade Federal Fluminense (UFF)
dc.creatorCoblentz, Jacqueline
dc.creatorMotta, Mario M. S.
dc.creatorFernandes, Bruno F.
dc.creatorBurnier, Miguel N. [UNIFESP]
dc.creatorVianna, Raul N. G.
dc.date.accessioned2016-01-24T13:52:10Z
dc.date.accessioned2023-09-04T18:18:47Z
dc.date.available2016-01-24T13:52:10Z
dc.date.available2023-09-04T18:18:47Z
dc.date.created2016-01-24T13:52:10Z
dc.date.issued2009-01-01
dc.identifierCurrent Eye Research. Philadelphia: Taylor & Francis Inc, v. 34, n. 11, p. 925-927, 2009.
dc.identifier0271-3683
dc.identifierhttp://repositorio.unifesp.br/handle/11600/31236
dc.identifier10.3109/02713680903205220
dc.identifierWOS:000272676800002
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8613018
dc.description.abstractBackground/Aims: To evaluate and compare obtained mydriasis with phenylephrine 10% associated with tropicamide 1% in type 2 diabetics and non-diabetic patients. Methods: A total of 50 patients ( 100 eyes) scheduled for fundoscopy were dilated with phenylephrine 10% and yropicamide 1% (group 0: n=20 type 2 diabetic patients, 40 eyes, and group 1: n=30 non-diabetic patients, 60 eyes). Only one drop per eye of each drug was administered. in both groups, pupil diameter was measured after 40 minutes of eye drops instillation.Results: Both groups were similar regarding age (p = 0.06, Mann-Whitney test). Mean pupil diameter in group 0 was 8.57 and 8.73 in group 1. There was no statistic difference between both groups (p = 0.44). Pupil diameter was greater than 7 mm in all patients (100%).Conclusion: When an appropriate drug combination is used, diabetic patients can achieve mydriasis as satisfactory as non-diabetic patients, allowing adequate fundus examination and/or retinopathy treatment.
dc.languageeng
dc.publisherTaylor & Francis Inc
dc.relationCurrent Eye Research
dc.rightshttp://journalauthors.tandf.co.uk/permissions/reusingOwnWork.asp
dc.rightsAcesso restrito
dc.subjectAdrenergic drugs
dc.subjectDiabetes mellitus
dc.subjectFundus examination
dc.subjectMydriatic drugs
dc.subjectPupil diameter
dc.titleComparison between Obtained Mydriasis in Type 2 Diabetics and Non-Diabetic Patients
dc.typeArtigo


Este ítem pertenece a la siguiente institución